Phase III Trial Costs Estimated at $19 Million

Drug Industry Daily
A A
It cost an average of $19 million to get new drugs through their pivotal clinical trials and onto the market, a new analysis has found.

To View This Article:

Login

Subscribe To Drug Industry Daily